# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Feb 3, 2026

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 2, 2026, 18:36 ET
- Period: 2026-02-02
- Accession: 0001628280-26-004738
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000162828026004738/amrx-20260202.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000162828026004738/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000162828026004738/amrx-20260202.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-004738. Last ingested by Listed: Nov 3, 2026, 08:12 ET. No prices; not investment advice.